tarka 180 mg/2 mg kapszula
abbott laboratories kft. - trandolapril; verapamil -
acitretin orifarm 10 mg kapseli, kova
orifarm generics a/s - acitretin - kapseli, kova - 10 mg - asitretiini
acitretin orifarm 25 mg kapseli, kova
orifarm generics a/s - acitretin - kapseli, kova - 25 mg - asitretiini
tarka 180/2 film tablet, 28 adet
abbott laboratuarlari İthalat İhracat ve tİc. ltd. Ştİ. - trandolapril and verapamil - trandolapril ve verapamil
tarka 180 mg/2 mg filmtabletta
viatris healthcare ltd. - trandolapril; verapamil -
tarka 180 mg/2 mg filmtabletta
eu pharma kft. - trandolapril; verapamil -
tarka lp, gélule à libération prolongée
abbott france - chlorhydrate de vérapamil - gélule - 180 mg - composition pour une gélule > chlorhydrate de vérapamil : 180 mg > trandolapril : 2 mg - inhibiteurs de l'enzyme de conversion (iec) et inhibiteurs calciques.
tarka 180/2 milligram modified-release tablets
abbott laboratories ireland ltd - verapamil hydrochloride trandolapril - modified-release tablets - 180/2 milligram
tarka 4/240 trandolapril 4mg & verapamil hydrochloride 240mg tablet
viatris pty ltd - trandolapril, quantity: 4 mg; verapamil hydrochloride, quantity: 240 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; povidone; hypromellose; sodium stearylfumarate; microcrystalline cellulose; sodium alginate; magnesium stearate; hyprolose; macrogol 400; macrogol 6000; purified talc; colloidal anhydrous silica; titanium dioxide; iron oxide red; iron oxide yellow; iron oxide black; docusate sodium - tarka is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.
tarka tablet (extended-release)
abbott laboratories, limited - verapamil hydrochloride; trandolapril - tablet (extended-release) - 180mg; 2mg - verapamil hydrochloride 180mg; trandolapril 2mg - miscellaneous calcium-channel blocking agents